Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: A population-based study

International Journal of Cancer

Volumn 133, Issue 7, 2013, Pages 1713-1720

  Farzan, Shohreh F ^a   Waterboer, Tim ^b   Gui, Jiang ^a   Nelson, Heather H ^c   Li, Zhongze ^a   Michael, Kristina M ^b   Perry, Ann E ^a   Spencer, Steven K ^a   Demidenko, Eugene ^a   Green, Adele C ^d   Pawlita, Michael ^b   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF MINNESOTA   (United States)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

case control; human papillomavirus; meta analysis; population based; squamous cell carcinoma

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS ALPHA; HUMAN PAPILLOMAVIRUS BETA; HUMAN PAPILLOMAVIRUS GAMMA; HUMAN PAPILLOMAVIRUS TYPE 10; HUMAN PAPILLOMAVIRUS TYPE 101; HUMAN PAPILLOMAVIRUS TYPE 103; HUMAN PAPILLOMAVIRUS TYPE 107; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 17; HUMAN PAPILLOMAVIRUS TYPE 2; HUMAN PAPILLOMAVIRUS TYPE 20; HUMAN PAPILLOMAVIRUS TYPE 23; HUMAN PAPILLOMAVIRUS TYPE 24; HUMAN PAPILLOMAVIRUS TYPE 27B; HUMAN PAPILLOMAVIRUS TYPE 36; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 48; HUMAN PAPILLOMAVIRUS TYPE 49; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 50; HUMAN PAPILLOMAVIRUS TYPE 57; HUMAN PAPILLOMAVIRUS TYPE 65; HUMAN PAPILLOMAVIRUS TYPE 7; HUMAN PAPILLOMAVIRUS TYPE 75; HUMAN PAPILLOMAVIRUS TYPE 76; HUMAN PAPILLOMAVIRUS TYPE 77; HUMAN PAPILLOMAVIRUS TYPE 88; HUMAN PAPILLOMAVIRUS TYPE 92; HUMAN PAPILLOMAVIRUS TYPE 95; HUMAN PAPILLOMAVIRUS TYPE 96; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SKIN CARCINOMA; SYSTEMATIC REVIEW; UNITED STATES; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

CASE-CONTROL; HUMAN PAPILLOMAVIRUS; META-ANALYSIS; POPULATION-BASED; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GAMMAPAPILLOMAVIRUS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SKIN; SKIN NEOPLASMS; UNITED STATES;

EID: 84880263010     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28176     Document Type: Article

References (53)

1. NCI. Skin Cancer, vol. 2012.
2. Casabonne D, Waterboer T, Michael KM, et al,. The seroprevalence of human papillomavirus by immune status and by ethnicity in London. Infectious Agents Cancer 2009; 4: 14.
3. Waterboer T, Neale R, Michael KM, et al,. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 2009; 90: 1986-98.
4. de Koning MN, Weissenborn SJ, Abeni D, et al,. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 2009; 90: 1611-21.
5. Bernard HU, Burk RD, Chen Z, et al,. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-9.
6. Buck CB, Trus BL,. The papillomavirus virion: a machine built to hide molecular Achilles' heels. Adv Exp Med Biol 2012; 726: 403-22.
7. Ekstrom J, Bzhalava D, Svenback D, et al,. High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions. Int J Cancer. Journal international du cancer 2011; 129: 2643-50.
8. Patel AS, Karagas MR, Perry AE, et al. Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol 2008; 128: 2888-93.
9. Forslund O, Iftner T, Andersson K, et al,. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196: 876-83.
10. Iftner A, Klug SJ, Garbe C, et al,. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003; 63: 7515-9.
11. Karagas MR, Waterboer T, Li Z, et al,. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010; 341: c2986.
12. Waterboer T, Abeni D, Sampogna F, et al,. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 2008; 159: 457-9.
13. Andersson K, Michael KM, Luostarinen T, et al,. Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer. Am J Epidemiol 2012; 175: 685-95.
14. Bouwes Bavinck JN, Neale RE, Abeni D, et al,. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010; 70: 9777-86.
15. Iannacone MR, Gheit T, Waterboer T, et al,. Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prevention 2012; 21: 1303-13.
16. Paradisi A, Waterboer T, Sampogna F, et al,. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br J Dermatol 2011; 165: 782-91.
17. Plasmeijer EI, Pandeya N, O'Rourke P, et al,. The Association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study. Cancer Epidemiol Biomarkers Prevent 2011; 20: 1171-7.
18. Karagas MR, McDonald JA, Greenberg ER, et al,. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88: 1848-53.
19. Karagas MR, Greenberg ER, Spencer SK, et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer. Journal international du cancer 1999; 81: 555-9.
20. Karagas MR, Nelson HH, Sehr P, et al,. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 389-95.
21. Kricker A, Armstrong BK, English DR,. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994; 5: 367-92.
22. Kricker A, Armstrong BK, English DR, et al,. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer-a case-control study. Int J Cancer 1991; 48: 650-62.
23. Sehr P, Muller M, Hopfl R, et al,. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002; 106: 61-70.
24. Sehr P, Zumbach K, Pawlita M,. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001; 253: 153-62.
25. Waterboer T, Sehr P, Michael KM, et al,. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005; 51: 1845-53.
26. Michael KM, Waterboer T, Sehr P, et al,. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathogens 2008; 4: e1000091.
27. Dondog B, Clifford GM, Vaccarella S, et al,. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prevent 2008; 17: 1731-8.
28. Antonsson A,. Review: antibodies to cutaneous human papillomaviruses. J Med Virol 2012; 84: 814-22.
29. Feltkamp MC, de Koning MN, Bavinck JN, et al,. Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol 2008; 43: 353-60.
30. International Agency for Research on Cancer I, Human Papillomaviruses, 2007.
31. International Agency for Research on Cancer I, A review of human carcinogens. Part B: Biological agents 2009.
32. Struijk L, Hall L, van der Meijden E, et al,. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prevent 2006; 15: 529-35.
33. Breslow NE, Day NE,. Statistical Methods in Cancer Research Volume 1-The Analysis of Case-Control Studiesed. Lyon, France: IARC, 1980.
34. Miettinen O,. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226-35.
35. Karagas MR, Cushing GL, Jr, Greenberg ER, et al,. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 2001; 85: 683-6.
36. Subramanian A, Tamayo P, Mootha VK, et al,. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-50.
37. Andersson K, Waterboer T, Kirnbauer R, et al,. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prevent 2008; 17: 189-95.
38. Feltkamp MC, Broer R, di Summa FM, et al,. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695-700.
39. Birkeland SA, Storm HH, Lamm LU, et al,. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer. Journal international du cancer 1995; 60: 183-9.
40. Kiviat NB,. Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Seminars Cancer Biol 1999; 9: 397-403.
41. Arron ST, Ruby JG, Dybbro E, et al. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol 2011; 131: 1745-53.
42. Jackson S, Harwood C, Thomas M, et al,. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14: 3065-73.
43. Cornet I, Bouvard V, Campo MS, et al,. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types. J Virol 2012; 86: 2366-70.
44. Viarisio D, Mueller-Decker K, Kloz U, et al,. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathogens 2011; 7: e1002125.
45. Muench P, Probst S, Schuetz J, et al,. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res 2010; 70: 6913-24.
46. Lazic D, Hufbauer M, Zigrino P, et al,. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2. J Virol 2012; 86: 7943-52.
47. Tomlins C, Storey A,. Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. Carcinogenesis 2010; 31: 2155-64.
48. Borgogna C, Zavattaro E, De Andrea M, et al,. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology 2012; 423: 195-204.
49. Sperling T, Oldak M, Walch-Ruckheim B, et al,. Human Papillomavirus Type 8 interferes with a novel C/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and langerhans cell migration. PLoS Pathogens 2012; 8: e1002833.
50. Chen D, McKay JD, Clifford G, et al,. Genome-wide association study of HPV seropositivity. Hum Mol Gene 2011; 20: 4714-23.
51. Patel AS, Karagas MR, Pawlita M, et al,. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int. J Cancer. Journal international du cancer 2008; 122: 2377-9.
52. de Martel C, Ferlay J, Franceschi S, et al,. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
53. Lomas A, Leonardi-Bee J, Bath-Hextall F,. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-80.